Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. AchieveRx Quit Co. (The) market cap is $623.59M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. AchieveRx Quit Co. (The) 52 week high is $8.64 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AchieveRx Quit Co. (The) 52 week low is $2.62 as of November 17, 2026.
AchieveRx Quit Co. (The) stock price today is $6.05.
AchieveRx Quit Co. (The) stock price yesterday was $6.06.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. AchieveRx Quit Co. (The)'s P/E ratio is -4.39.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. AchieveRx Quit Co. (The) P/B ratio is 3.6809.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. AchieveRx Quit Co. (The) 50-day moving average is $7.08.